Observational study of clinical toxicity with different formulations of docetaxel in breast cancer patients Eva González-Haba-Peña; Margarita Garrido-Siles; María Jose Martínez-Bautista; Amparo Burgos-San José; Azucena Aldaz-Pastor; Irene Mangues-Bafalluy;

Inclusion of omalizumab in a trastuzumab desensitization protocol Ester María Barreiro-Fernández; Manuel David Gil-Sierra; María del Pilar Briceño-Casado; Carmen Martínez-Díaz; Esmeralda Ríos-Sánchez;

Observational real world data with palbociclib associated to hormone therapy for advanced breast carcinoma Teresa Sampedro-Gimeno; Rubén Pampín-Sánchez; Francisco Javier Barbazán-Vázquez; Virginia Reguero-Cuervo; Virginia Galeazzi-Martínez; Ignacio Pelaez-Fernández;